[ad_1]
A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA’s Molecular and Clinical Genetics Devices Panel of the Medical Dev..
A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA’s Molecular and Clinical Genetics Devices Panel of the Medical Dev..
